ArticleFrontiers in endocrinology2026
Association of psychological symptoms with poor sleep quality in adults: a cross-sectional network analysis and effect modification by thyroid hormones.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Psychological symptoms and poor sleep quality (PSQ) frequently co-occur and impose a substantial public health burden. This study aimed to investigate the association between psychological symptoms and PSQ, examine whether thyroid hormones modify this association, and characterize the mixed psychological -sleep -thyroid symptom network among adults undergoing routine health examinations. Methods: This study enrolled 3,694 adults who underwent routine health screening at the Health Management Center of Sichuan Provincial People's Hospital between April 2022 and December 2025. Participants were categorized into a PSQ group and a normal control group based on their Pittsburgh Sleep Quality Index (PSQI) scores. Modified Poisson regression with robust sandwich variance estimators (HC3) was used to estimate prevalence ratios (PRs) for the association between psychological symptoms (Symptom Checklist-90, SCL-90) and PSQ. Effect modification by thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) was tested using multiplicative interaction terms in stratified and continuous-variable models. Finally, a mixed "psychological-sleep-thyroid" symptom network was constructed to calculate the expected influence and bridge strength of the nodes. Results: After adjusting for potential confounders, participants in the highest quartile of GSI scores exhibited a 5.81-fold increased prevalence of PSQ compared to those in the lowest quartile (PR = 5.81, 95% CI: 4.86-6.95, P < 0.001). Effect modification analysis revealed that FT3 significantly modified the association between psychological symptoms and PSQ (PR for interaction per 1-unit GSI increase = 1.35, 95% CI: 1.24-1.46, P < 0.001), with the prevalence ratio increasing from 1.61 (95% CI: 1.53-1.69) in the below-median FT3 group to 2.26 (95% CI: 2.02-2.53) in the above-median FT3 group. The modifying effects of TSH and FT4 were not statistically significant in continuous models. Symptom network analysis demonstrated that depressive symptoms, anxiety, and subjective sleep quality were among the nodes with the highest expected influence. Moreover, daytime dysfunction and FT3 demonstrated substantial cross-module bridge expected influence. Discussion: In this cross-sectional study, elevated psychological symptom severity was positively associated with PSQ prevalence, and this association appeared to be modified by FT3 levels. Depressive symptoms and subjective sleep quality emerged as central nodes, while daytime dysfunction and FT3 appeared to serve as key bridge nodes across psychological, sleep, and thyroid domains. Longitudinal studies are needed to clarify temporal relationships and evaluate whether targeting FT3-related pathways and daytime functioning may help reduce sleep disturbances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.